Summary
Aragen Life Sciences has submitted its Draft Red Herring Prospectus (DRHP) to Sebi for an Initial Public Offering (IPO) that includes an 800 crore fresh issue and an Offer For Sale (OFS). The funds raised will be used for debt repayment, capacity expansion, and equipment purchases, following strong financial growth with revenue reaching Rs 2,178 crore and profit Rs 258 crore in FY26.